Recently, an international team of researchers based in Texas and Japan, have been experimenting with an obesity treatment nicknamed “Fatostatin”, that has been shown to not only make mice lose weight, but also shows great promise in the treatment of diabetes, and even the lowering of cholesterol.  These scientists have identified a small molecule therapy program that alters the genetic code involved in the way the human body turns food into fat.  Because it has been proven to be effective in dramatic weight loss, and in lowering cholesterol levels, it has been considered to be an efficient treatment in the struggle to treat diabetes.

This Fatostatin drug works to block increases in body weight, fat accumulation, and blood glucose, even with unconstrained food intake.  It is important to note that the only successful tests done so far have only taken place with the use of animal subjects, but the scientists are very optimistic.  They believe this new, experimental drug could have a huge impact, not only in weight loss, but in controlling cholesterol levels, blood glucose levels, and insulin levels in the body, which could be used to treat diabetes.  The scientists believe it goes back to the origin of fat synthesis, where scientists believe they have actually found a way for the body to stop gaining weight.  But is this even possible?

This new Fatostatin drug works by interfering with element binding proteins that influence a group of genes that are triggered during excessive food consumption.  It works by essentially, switching off the body’s negative reaction to food, by turning food directly into energy, or waste, and not stored fat.  After one month of treatment, the mice used in this study have seen a 12% reduction in their body fat levels, as well as a staggering 70% drop in their blood sugar levels.  As promising as this may seem, many obesity drugs, even with prior success on animal test patients, have had little success in humans.  But according to some high ranking pharmaceutical consultants, this drug could be the way of the future for not only fighting obesity, but curing complications to obesity like cholesterol, heart disease and diabetes.

According to some in the bio-tech industry, as well as prominent pharmaceutical consultants, further testing is needed to really find out if Fatostatin is the new miracle drug of the future, or if it’s just a flash in the pan.  But as new technology surfaces in the ever evolving Bio-Tech industry, molecular breakthroughs like this could be commonplace.  As for now, scientists are very excited about Fatostatin and are looking to test it out on humans soon.

If you liked this article, tell all your friends about it. They’ll thank you for it. If you have a blog or website, you can link to it or even post it to your own site (don’t forget to mention www.smartconsultinggrp.com as the original source.

Don’t Forget to Subscribe by RSS or Email:

Many arguments have been made both for and against pharmaceutical outsourcing in the pursuit of achieving some sort of competitive advantage.  By allowing outside firms to concentrate on specific tasks, many pharmaceutical firms feel they can increase not only their performance, but deliver a better product in the end.  Too much outsourcing may have some negative effects as well.  Too much outsourcing may reduce organizational innovation within the company; it may shift certain knowledge to supplier organizations which may reduce the overall activity of the larger company.  However, pharmaceutical companies for years have worked hand in hand with a pharmaceutical consultant to develop a safer and more effective product.

Pharmaceutical companies all over the world are increasingly turning to outsourcing in an attempt to increase their overall productivity and competitiveness.  Large pharmaceutical firms are turning to smaller more specific firms to help them break through to the next level of improvement and innovation.  In order to meet the ever evolving market demands of the 21st century large pharmaceutical companies are being forced to improve the way they operate, based on innovation and efficiency.  Outsourcing for these large companies can have many advantages, but there are many barriers in the process.

One of these barriers to the global conflagration of outsourcing efficiency is that most outsourcing services are very specific to only one or two jobs.  Usually these smaller companies have very limited capabilities which means the larger companies have to look to more and more outsourcing firms to fulfill their outsourcing needs.  This makes the manufacturing process even more confusing not to mention costly.  Because of this fragmented market it can be difficult for larger pharmaceutical companies to achieve the kind of maximum efficiency they’re looking for.  That is why many pharmaceutical companies have turned to pharmaceutical consulting firms who can advise the best plans for the company to achieve the most innovation and efficiency possible.

Pharmaceutical consulting firms are designed to advise companies on every aspect of their business, to help them be more successful and reach maximum profitability.  A pharmaceutical consulting firm can give your pharmaceutical business a plan on how to achieve outsourcing efficiency, as well as fill you in on process innovation tips you may not be aware of.  They can also help your business with licensing, business development, brand management, as well as product distribution and process efficiency training.  They can look into your business and see what you can do to make your product better, safer and your business more efficient.  Before looking to outsource a vital part of your pharmaceutical company, discuss the plan first with a pharmaceutical consulting firm whose job it is to make sure that you will make the best decision for your company, not to mention your consumers as well.

If you enjoyed this article, please feel free to post it to your site or blog and forward this link to your friends. Have a great day!

Don’t Forget to Subscribe by RSS or Email:

Emerging third world markets to big drug companies has come to be the same as California gold was to miners in the 1800’s.  Every major drug company is clamoring to get their stake in these emerging markets, and is stopping at nothing to do it.  But just as many of the biggest drug making companies in the world have their sights clearly set on these emerging markets, many of these countries are turning to generic drugs instead.  This has always been the trend in less developed areas of the world, but analysts expect as the middle classes in most of these developing nations grow, there will be more of a demand for branded medicines, that may be more expensive, but are seen as having better quality.

That is why it is no surprise that the acquisition of generic drug companies, by larger branded drug corporations, is on the rise.  As these larger drug companies are scrambling to buy the rights to generic drugs they can sell from their own, better trusted brand, companies like Wal-Mart and Kroger are clamoring to get a piece of the action.  These companies know if they can buy generic drugs from these emerging markets at bottomed out prices, they can sell them in their retail outlets for a large profit.  Cheap copycat generic drugs are becoming a necessity to some of these retail pharmaceutical companies because their losing more and more money everyday to well established drug companies, while at the same time having these cheap drugs attracts more customers to their stores.

But according to many in the pharmaceutical sales consulting industry, this may be a dangerous trend.  Because companies like Wal-Mart and Kroger are most likely buying their generic drugs from poorer countries like India and Indonesia, this is causing a big concern about the quality of the drugs.  The FDA is trying to crack down on the rising sales of generics from emerging markets to the U.S and other European countries, but the truth is, there’s really not much they can do about it.  As the need for cheaper, more available drugs continues to rise, there will be no choice but to turn to generic drugs on a massive scale.

But the large drug companies have not thrown in the towel just yet.  With the emergence of generic drugs in these emerging markets, drug companies have started to turn more to generic branded medicine of their own.  They have decided to buy the rights of much of this generic medicine themselves, so they can put their brand on it, giving it more legitimacy in markets around the world.  With all that being said, there’s one thing we do know, that this is only the beginning of a colossal struggle between the smaller generic drug companies and the large branded drug corporations.

If you enjoyed this article, please feel free to post it to your site or blog and forward this link to your friends. Have a great day!

Don’t Forget to Subscribe by RSS or Email:

Starting a pharmaceutical sales consulting firm can be a rewarding and challenging profession.  People think of a pharmaceutical sales consultant as someone who knows medicine, someone that is an expert salesman, and who has at least a Master’s Degree.  The truth is that becoming a pharmaceutical sales consultant may not be as hard as you think and takes determination and persistence, more than anything else.

The reality is that most pharmaceutical sales consulting firms do not even require a technical or science degree.  Some will even train the consultant and do not even require a bachelor’s degree.  Also, it is not necessarily vital that you have great sales experience, as long as you seem like a smart and ambitious candidate.  What they do care about is your ability to get in front of doctors and stay in front of doctors.  If you only have a business degree and are looking for a purely sales orientated job, then being a pharmaceutical rep. may appeal to you too.

Pharmaceutical sales reps make good salaries, and have potential to make over 20-25k commissions, drive company cars, and attend national conventions.  However, this is a competitive profession and standing out might not be easy.  There are over 30,000 reps in the top 5 companies alone, notwithstanding the rest of their market.  If you are not moving up the company ladder as fast as you would like, you could take a look at the clinical diagnostics arena. This sector may be a little less high end, but has a little more than a thousand representatives overall.

Since it is difficult to stand out in a sales force of such a large size you must be creative to stand apart from the competition.  Through drive, intelligence, technical understanding, and sales savvy you will be able to stand apart from the competition and make a name for yourself throughout the industry.  Getting a sales job as a pharmaceutical consultant can be a great career for someone who is business savvy, and if you know how to sell, then the rest will come as you go.

If you are not progressing in your career as you would have liked, set yourself apart in the lab products arena where competition is less fierce and you have a better likelihood of succeeding.  But remember, if you can stand up to the challenge, and work hard through determination and skill, then you can be successful in the pharmaceutical industry, which will lead to better positions and more earning potential.  If you think you have what it takes to be a pharmaceutical sales consultant, then don’t waste another minute and contact your local recruiter.

If you enjoyed this article, please feel free to post it to your site or blog and forward this link to to your friends. Have a great day!

Don’t Forget to Subscribe by RSS or Email:

How many times have you seen a product last for a year and then disappear into anonymity? It happens much more frequently than you think, and basically because the product’s creators forgot to consider a few simple, but important factors that could have saved their product’s life in the market. These factors are applicable to most business areas, but in the pharmaceutical business, they are the worst decisions to be made.

Here is a list of the most common mistakes to avoid when launching any product in the health care industry:

1.    NO VARIATION: Vanishing cream under a different name is just vanishing cream. Don’t expect to become a market leader with that. But if your product is innovating in some aspect, you must tell the world about it. Prove that your product is better, more effective, lighter, or offers more benefits than your competitors. This is the only way your product can survive the strongest competition: sales. Find a pharmaceutical consulting firm to help you with this.

2.    POOR INITIAL INVESTMENT: If you are the type of person who thinks that your product is so good that it will sell by itself, you should start re-considering your thoughts. Market positioning comes together with an important investment. Strong marketing campaign, effective promotion, and clever strategy are the keys to give your product an important place in the market. This is not for free.

3.    SEGREGATED EFFORTS: The different parts of a plane can’t fly by themselves. Not even if you put them all together. Every part has a place and a role. The same happens with the different aspects of launching a product. Price, publicity, promotion, marketing strategies, etc., should be integrated into one single effort to build your image and get your place in the market. Doing the contrary will make poor use of your resources and your results will be disappointing. A good pharmaceutical consulting firm will help you even build a better business plan.

4.    STANDARD PRODUCT FOR ALL COUNTRIES: Popular, soft, and creamy cosmetics in the North can create big allergies in the South. Clinical tests will help you determine what things to consider among regional or racial differences. Purchasing habits, treatments, and type of consumption vary from one country to another. If you stick to only one type of product, with no variation, you may lose your share in a country’s market.

5.    NO INFORMATION: Your product looks nice, has a catchy name, a beautiful box and practical presentation. But, what is it for? People need to know what it does, why it is better and the benefits they can get by consuming it. Remember, doctors are the ones advertising your product by word of mouth, so they are the first to be informed. Consumers, on the other part, can become completely loyal to your brand if they know what your product does for them.

As you read this information you might have come to notice that you were already making some (or all) of these mistakes. Don’t panic. You still have the time and chance to revert the situation. The important thing here is that you are aware of the steps that you make and find the appropriate help to find your way into this competitive market. Just remember what things you need to avoid and focus on maximizing your opportunities by optmimizing your resources. And if you finally launch your product, well, good luck!

So your product is ready. Beautiful bottles or tablet displays stare at you from the shelves, waiting for their opportunity to reach consumers’ homes and prove that the years spent in research were worth the effort. You feel proud and ready to contribute with your product to save lives, ease the pain, or protect from virus or bacteria. This is your moment. But wait. Your journey to the Hall of Fame has just started. The end of the line is the consumer, but to get there, you require a lot of extra effort, hard work, and a good business plan.

In general, there are 5 important factors that can make of a new medication or treatment a real success. They have been depicted by many pharmaceutical consultants and are listed below.

Innovation: Vital for the creation and launching processes. The new product must be better than those existing in the market. More of the same will not sell. How well is your product doing in this area?

Initial investment: Little money, little success. The money you invest at the beginning must ensure your product’s initial market positioning. There is a direct relation between money spent on effective marketing campaigns and product success. The idea is to obtain a good share of the market in the first two years. The most effective campaigns are not necessarily the most expensive, though.

Integration into a synergic campaign: Maximize your opportunities by integrating all your decisions and actions to pursue your one objective: market positioning. Some companies are even including social networks into their campaigns.

Customize product according to each country’s needs: Haiti does not have the same needs as the UK or Chile, for example. Adapt your product and/or promotion according to the market you are facing: price, market niche, people’s habits, and idiosincracy, race or even skin pigmentation are important here.

Inform consumers: Communicate the differences and advantages in comparison to existing medicines or healthcare products. How will they buy your product if they don’t know it exists or what it does? If a patient or consumer knows what his medication or product is doing for him and the benefits he obtains, he will remain loyal to the brand.

Pharmaceutical consultants will usually provide you with all the important information and help to make your health care product a success in sales. They can help you create your businees plan and develop all the appropriate strategies to reach the market in the best possible condition. They will help you with your “P” list (price, product, promotion, publicity, and place in the market) that will permit the best commercialization of your product .

You should be able to set clear differences with the other products (innovation), make the adequate investments in the right media, and at the same time be able to customize your strategies according to your market’s needs. Those are the key issues to get your market positioning and make it stay in the minds of doctors, patients and/or consumers in general for a long, long time. So, stop staring at your product, thinking about your good ideas. The time to conquer the market has come!